News Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc (NASDAQ: VACC), a…AndyNovember 6, 2023
News United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis Up to 60,000 patients in the United States may have PPF, with only one approved therapy available SILVER SPRING, Md.…AndyNovember 6, 2023
News BioBuzz: Addimmune Prepares to go Public, Initiate Phase Ib HIV Trial By Alex Keown | October 31, 2023 - Addimmune, currently American Gene Technologies HIV-focused research, is expected to become a publicly traded…AndyNovember 6, 2023
News Johnson & Johnson Innovation Names Awardees in the Advancing Oncology InnoVAtion QuickFire Challenge October 25th, 2023 – Johnson & Johnson Innovation, in collaboration with Carilion Clinic Innovation, Verge Alliance (with support from City of…AndyNovember 6, 2023
News Indo US Bridging Rare Summit Heralds a New Era of Cooperation for Rare Diseases Orphan Drugs Development The FDA’s Commissioner, Dr. Robert M. Califf, recently visited India and shared his opinion on India’s Unique Opportunity and Important…AndyNovember 6, 2023
News Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF) Are you curious about the world of transformative regenerative medicine and stem cell research? Are you eager to understand how…AndyNovember 5, 2023
News QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis…AndyNovember 2, 2023
News ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines Six new products that can be used to detect residual host cell genomic DNA (gDNA) MANASSAS, Va. and ROCKVILLE, Md., Oct. 30, 2023 /PRNewswire/…AndyOctober 30, 2023
News BioHealth Innovation Inc. (BHI) Announces the Addition of New Technical Writer and Program Manager, Jon Nelson ROCKVILLE, MARYLAND, October 30, 2023 – BioHealth Innovation Inc. (BHI) proudly welcomes Jon Nelson to its innovative team. Jon joins…AndyOctober 30, 2023
News BRAINBox Solutions Announces Initial Series B Investments to Support U.S. Regulatory Clearance, Initial Commercialization of BRAINBox TBI Concussion Diagnostic/Prognostic Test RICHMOND, Va., Oct. 30, 2023 /PRNewswire/ -- BRAINBox Solutions today announced initial investments into the company's Series B financing to support U.S. regulatory…AndyOctober 30, 2023